for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

Eli Lilly profit misses on weaker drug demand

Profits fell short of forecasts at Eli Lilly as U.S. progress on vaccines cut demand for the firm's COVID-19 therapies. Julian Satterthwaite reports.

最新のビデオ
エンタテインメント
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up